Baxter International has acquired Baxa, the US-based developer of pharmacy technology, for a cash consideration of $380m.
Baxter Medical Products develops, manufactures and markets products used in the delivery of fluids and drugs to patients.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Baxter Medical Products business president Robert Davis said the transaction will allow Baxter to provide a broader range of solutions for the safe preparation and delivery of IV medications.
"We believe Baxa’s expertise in safely preparing IV and oral liquid medications, and their shared commitment toward improving patient care through innovative drug preparation and delivery technology, will benefit patients around the world," Davis added.
Baxter’s product portfolio includes ExactaMix, ExactaMed syringes, NeoThrive enteral feeding system, enteral syringes and accessories and the DoseEdge pharmacy workflow manager for managing IV and oral dose preparation activities.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalData
